APCER
Life Sciences, the truly global provider of safety, medical,
regulatory, and technology services, announced today that Sutinder
Bindra, MD, has joined the company as Global Head of Medical Affairs.
Dr. Bindra, who was most recently Head of Medical and Clinical Affairs
for Pfizer’s Asia-Pacific Region, will lead a fully integrated team to
provide Medical Affairs services globally, including the Asia Pacific
region, from APCER’s newly established office in Hong Kong.
“Our desire is to continually strengthen and expand both the range of
services we provide and our local presence throughout the world,” said
Suneet Walia, CEO of APCER Life Sciences, Inc. “Dr. Bindra’s extensive
experience and demonstrated leadership in medical and clinical affairs
are precisely what we need to build our global capabilities and help our
clients with the challenges of developing and marketing pharmaceuticals
in a resource-constrained environment.”
Dr. Bindra worked for Pfizer and its legacy companies for more than
seventeen years. As Head of Pfizer’s Asia Medical and Regulatory
Operations in Hong Kong, Dr. Bindra grew the organization to include a
multitude of new functions and responsibilities, including the expansion
of clinical research and drug development in Asia; creation of the
Outcomes Research and Health Technology Assessment functions;
implementation of new technology platforms for Medical Information; and
collaboration and training with regulatory authorities. He pioneered
business orientation programs for new Medical Managers, processes for
the evaluation and conduct of Investigator-Initiated Research (IIR), and
collaboration with key opinion leaders (KOLs).
“The importance of a global approach to Medical Affairs is growing in
every organization, as the hurdles for reimbursement are becoming higher
than those for regulatory approval in more and more countries,” said Dr.
Bindra. “I’m pleased to join an organization that recognizes the huge
role that Medical Affairs and Outcomes Research have to play in the
success of pharmaceutical and device businesses and is committed to
developing and delivering cohesive, technology-enabled solutions and
services.”
Dr. Bindra had several years of clinical experience in Internal Medicine
and Cardiology before joining the pharmaceutical industry in 1993. In
addition to an MBBS and an MD in Internal Medicine, he has a Masters in
Pharmaceutical Medicine from Hibernia University in Ireland; Advanced
Management Certificate from the Thunderbird University, Arizona, USA;
and Leadership Development Certificate from the Harvard Business School,
USA. Dr. Bindra is a recipient of the WE Upjohn Award for Clinical
Excellence in Pfizer and has several scientific publications to his
credit.
The new APCER Life Sciences Hong Kong office is located in the Bank of
East Asia Harbour View Centre in Wan Chai, at the heart of the city’s
Central Business District. It overlooks the Victoria Harbour and is a
short walk from the Hong Kong Convention and Exhibition Centre.
About APCER Life Sciences
APCER Life Sciences is committed to improving health in partnership with
its clients. It brings together safety, medical, regulatory, and
technology resources from around the world to ensure that patients
receive the safest, most effective therapies possible.
To learn how APCER Life Sciences works together for better health,
please follow the company on Twitter, LinkedIn, and Facebook; visit www.apcerls.com;
and contact
APCER at one of their global offices.
Contacts
APCER Life Sciences, Inc.
Jill Notte, 609-436-4714
Director,
Global Marketing
Copyright (2015) Business Wire.
All Rights Reserved.
Article source